|Delivery||Report Code||Available Format|
|24-72 Working Hours||LS10013|
Increasing infections and related diseases due to blood transfusion and blood donation are some of the major concerns in healthcare arena. Infectious diseases through blood transfusions occur due to the presence of microorganism, such as bacteria, virus and others parasites, in blood of donors which reach to receivers and infect their blood. Hepatitis and Acquired Immunodeficiency Syndrome (AIDS) are some of the major infectious diseases which pose great challenge to healthcare providers for the prevention and treatment of these diseases. To overcome this problem, various blood processing devices and blood processing consumables are used to prevent infection in blood transfusion and blood donation procedures. Blood processing devices are used in cell processing, blood refrigeration and centrifugation of blood cells. Blood processing consumables are used in collection of blood and grouping by various reagents.
The global blood processing devices and consumables market is segmented into blood processing devices and blood processing consumables. Blood processing devices segment is further sub-segmented into hematocrit centrifuges, blood bank refrigerators and blood grouping analyzers, blood bank freezers, blood warmers and blood cell processors. Blood processing consumables segment includes blood bags, blood administration sets, sedimentation tubes, blood collection tubes, blood collection needles, blood grouping reagents, coagulation reagents, vials, microscopic slides, hematology reagents, slide stainer, blood lancets, blood filters and test tube racks.
North America dominates the global blood processing devices and consumables market followed by Europe. This is due to increased awareness, developed economies and increased government support in the region. In addition, high disposable incomes and favorable reimbursement policies are also supporting in the growth of blood processing devices and consumables market in the region. The U.S., followed by Canada, is the largest market for blood processing devices and consumables in North America. Germany, France and the U.K. are some of the largest markets for blood processing devices and consumables market in Europe. However, Asia-Pacific represents the fastest growing region in the global blood processing devices and consumables market. This is due to increasing awareness and rising demand of blood and blood components for blood transfusion in the region. In addition, raising population and various government initiatives are also supporting the growth of blood processing devices and consumables market in Asia. Government initiatives and campaigns in countries, such as India and China, are trying to educate people about safe blood donations and transfusions procedures. This would develop opportunity for blood processing devices and consumable market in Asia.
Increasing demand from geriatric populations for blood and blood products is key driving factor for the global blood processing devices and consumables market. Increased open surgeries and surgical procedures require excessive blood to perform surgeries, leading to significant rise in demand of blood units from blood banks and blood donors. And this requires blood consumables and processing devices to collect and process it. Moreover, favorable reimbursement policies and growing government supports have also fueled the growth of global blood processing devices and consumables market.
However, stringent regulations and legislations is a key restraint of the global blood processing devices and consumables market. In addition, high cost of blood handling instruments and lack of skilled healthcare professionals to operate expensive instruments also obstructs the growth the global market. The global market is witnessing increased mergers and acquisitions between blood banks and government bodies.
Some of the major competitors in the market include Abbott Laboratories, Biomerieux SA, Becton, Dickinson And Company, Bio-Rad Laboratories, Danaher Corporation, Grifols International, Thermogenesis Corporation, Terumo Corporation, Roche Holdings AG, Macopharma SA, Immucor, Inc. and Haemonetics Corporation.